drugset
drugset / Trial / NCT05907850

Effects of Riboflavin in Mitigating Muscle Soreness in Ultra-marathon Athletes

NCT05907850 ↗

Phase 0 Completed 150 enrolled Steven Moore Racing the Planet · collab
RandomizedParallel-groupSingle-blindTreatment

Summary

The aim of this project is to investigate the effects of riboflavin, also known as vitamin B2, on preventing delayed onset muscle soreness (DOMS) in ultramarathon athletes through a randomized placebo-controlled study.

Timeline

Start
2023-06-23
Primary completion
2024-05-30
Completion
2024-05-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Riboflavin Other / unclassified 100 mg Oral

Indications

No indication recorded.